Member Login

 
Forgot password/Login issues?
Not a Member? Learn more.
  • Blog
  • Partnership
  • Contact
  • Cart (0)
  • Member Login
BCC Research
BCC Research
  • Member Login
  • Solution
    • Membership Membership
      • Academic
      • Corporate
    • Market Research
    • Custom Research
    • Company Index
    • Scorecard
  • Industries Industries
    • Life Sciences Life Sciences
      • Med Devices & Surgical
      • Cell Biology
      • Pharmaceuticals
      • Health Maintenance
    • Digital World Digital World
      • Instrumentation & Sensors
      • Safety and Security
      • Engineering
      • Photonics
      • Information Technology
    • Materials Materials
      • Advanced Materials
      • Plastics
      • Chemicals
      • Semiconductor
      • Nanotechnology
    • Energy & Sustainability Energy & Sustainability
      • Water-Membrane and Separations
      • Fuel Cell and Battery
      • Food
      • Energy
      • Manufacturing
      • Environment
  • Resources Resources
    • Blog
    • e-Course
    • Spotlights Library
    • Megatrends
    • Association Exclusives
    • Partnership
    • Market Research Studies
  • About
    • About BCC Research
    • Press Releases
    • Events
    • Careers
    • Contact
  • Beacon SearchBeacon Search

Or Ask your question to the BCC Research BEACON Beacon Research

  1. Company Index
  2. Takeda Pharmaceutical Co. Ltd.
  3. News

Takeda Pharmaceutical Co. Ltd.

  • Overview
  • Financial
  • In Reports
  • Products
  • History
  • Point of Contacts
  • News

In News

TAKEDA PHARMACEUTICAL CO LTD To Go Ex-Dividend On September 29th, 2025 With 0.88 USD Dividend Per Share - 富途牛牛

富途牛牛 - Jul 08, 2025

Is Takeda Pharmaceutical Company Limited (TAK) the Best Japanese Stock to Buy in 2025? - Yahoo Finance

Yahoo Finance - Feb 15, 2025

SEC Form 6-K filed by Takeda Pharmaceutical Company Limited - Quantisnow

Quantisnow - Jun 10, 2025

White & Case advises Takeda on divestment of assets to Hikma and Esteve - White & Case LLP

White & Case LLP - Feb 06, 2025

Takeda Expects Limited Exposure To US-China Tariffs - Takeda Pharmaceutical Co (NYSE:TAK) - Benzinga

Benzinga - May 08, 2025

Japan's Takeda raises full-year profit forecast amid restructuring - Reuters

Reuters - Oct 31, 2024

Takeda Completes Share Repurchase Program in May 2025 - TipRanks

TipRanks - May 31, 2025

Takeda Entering Pivotal Period, All Eyes on the Pipeline - Morningstar

Morningstar - May 19, 2025

Takeda: Buy Into Future Drug Pipeline Potential, Despite Recent Profit Headwinds - Seeking Alpha

Seeking Alpha - Mar 13, 2025

H-E-B is suing a Japanese pharmaceutical company. Here's why. - MySA

MySA - Apr 02, 2025

Takeda Pharmaceutical Co Ltd (TAK) Stock Price Down 4.42% on May 8 - GuruFocus

GuruFocus - May 08, 2025

Japan Credit Sales See Busiest June in Years as Buyers Seek Risk - Bloomberg

Bloomberg - Jun 12, 2025

BCC Research Beacon
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Thank you for your interest in BCC Research. You will be added to our mailing list.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact
  • 781-489-7301
  • info@bccresearch.com

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions

Please select categories of interest:

Check All